Inhibition of GSK3 or re-expression of the phosphor mutants in the CAP1-knockdown PANC-1 cells, both disrupting transient phosphorylation of CAP1, consistently led to reduced cancer cell motility and invasion. The gene discussed is CAP1; the disease is cancer.